Osteoporosis

Latest News

Image Credit: © Postmodern Studio - stock.adobe.com
FDA Approves Biosimilars Referencing Denosumab for Osteoporosis-, Cancer-Related Skeletal Events

March 4th 2025

The new approval expands the portfolio of denosumab biosimilars, increasing access and improving costs for patients.

Amgen Prolia Denosumab for injection in pre-filled syringe with protective cap. Monoclonal antibody used to treat bone loss in women post menopause
FDA Approves Biosimilar Denosumab-dssb to Treat Osteoporosis-, Cancer-Related Bone Loss

February 17th 2025

Coronavirus molecules.
Common Osteoporosis Treatments May Offer Protection Against COVID-19

January 29th 2025

Osteoporosis, Biosimilar, Denosumab | Image Credit: © eddows | stock.adobe.com
Data Further Confirm Proposed Denosumab Biosimilar Shows Similar Efficacy to Originator

December 2nd 2024

Man suffering from knee pain sitting on sofa.
FDA Grants MM-II Fast Track Designation for Treatment of Osteoarthritis Knee Pain

September 16th 2024

Latest CME Events & Activities

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...

2.0 Credits / Human Trafficking, Law

View More

Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies

1.0 Credit / Law, Pain Management, Opioids

View More

<1234